FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

INFUSION 51A, L.P.

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/19/2017 

3. Issuer Name and Ticker or Trading Symbol

Avant Diagnostics, Inc [AVDX]

(Last)        (First)        (Middle)

233 S. WACKER DRIVE, 84TH FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

CHICAGO, IL 60606       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   13283333   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Senior Secured Convertible Promissory Notes   11/16/2016   1/15/2018   Common Stock   $32500   $0.15   D    
Senior Secured Convertible Promissory Notes   12/2/2016   1/15/2018   Common Stock   $19500   $0.15   D    
Senior Secured Convertible Promissory Notes   12/6/2016   1/15/2018   Common Stock   $91000   $0.15   D    
Senior Secured Convertible Promissory Notes   12/12/2016   1/15/2018   Common Stock   $65000   $0.15   D    
Senior Secured Convertible Promissory Notes   12/13/2016   1/15/2018   Common Stock   $39000   $0.15   D    
Senior Secured Convertible Promissory Notes   6/19/2017   6/19/2020   Common Stock   $300000   $0.06   D    
Warrants   6/19/2017   6/19/2022   Common Stock   10833333   (1) $0.06   D    
Common Stock Purchase Rights   1/19/2019   6/19/2022   Common Stock   43333333   (2) $0.06   D    

Explanation of Responses:
(1)  Warrants acquired in two different transactions on same day involving 10,000,000 and 833,333 warrants.
(2)  Common Stock Purchase Rights acquired on same day in two different transactions involving 40,000,000 Common Stock Purchase Rights and 3,333,333 Common Stock Purchase Rights.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
INFUSION 51A, L.P.
233 S. WACKER DRIVE
84TH FLOOR
CHICAGO, IL 60606
X


Signatures
Jeffrey Stephens 6/28/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.